Curl Bio

Curl Bio is a drug development company that focuses on therapeutics for type-II diabetes, metabolic syndrome, and obesity. It also provides cell-based assay development and screening services, including non-alcoholic fatty liver disease (NAFLD) platform, pancreatic islet screening platform, and skeletal muscle screening platform.